NO20014101L - Stabilisert oral farmasöytisk blanding inneholdende iodid og iodat og fremgangsmåte - Google Patents

Stabilisert oral farmasöytisk blanding inneholdende iodid og iodat og fremgangsmåte

Info

Publication number
NO20014101L
NO20014101L NO20014101A NO20014101A NO20014101L NO 20014101 L NO20014101 L NO 20014101L NO 20014101 A NO20014101 A NO 20014101A NO 20014101 A NO20014101 A NO 20014101A NO 20014101 L NO20014101 L NO 20014101L
Authority
NO
Norway
Prior art keywords
iodate
pharmaceutical composition
oral pharmaceutical
composition containing
containing iodide
Prior art date
Application number
NO20014101A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014101D0 (no
Inventor
Yongun Duan
Kirk Dinehart
John Hickey
Jack Kessler
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Publication of NO20014101D0 publication Critical patent/NO20014101D0/no
Publication of NO20014101L publication Critical patent/NO20014101L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20014101A 1999-02-26 2001-08-23 Stabilisert oral farmasöytisk blanding inneholdende iodid og iodat og fremgangsmåte NO20014101L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/258,062 US6248335B1 (en) 1997-10-29 1999-02-26 Stabilized oral pharmaceutical composition containing iodide and iodate and method
PCT/US2000/004411 WO2000050046A1 (en) 1999-02-26 2000-02-22 Stabilized oral pharmaceutical composition containing iodide and iodate and method

Publications (2)

Publication Number Publication Date
NO20014101D0 NO20014101D0 (no) 2001-08-23
NO20014101L true NO20014101L (no) 2001-10-12

Family

ID=22978944

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014101A NO20014101L (no) 1999-02-26 2001-08-23 Stabilisert oral farmasöytisk blanding inneholdende iodid og iodat og fremgangsmåte

Country Status (19)

Country Link
US (1) US6248335B1 (de)
JP (1) JP2002537341A (de)
KR (1) KR100674324B1 (de)
CN (1) CN1344163A (de)
AT (1) AT413795B (de)
AU (1) AU778774B2 (de)
BR (1) BR0008509A (de)
CA (1) CA2366679C (de)
DE (1) DE10084290T1 (de)
DK (1) DK176595B1 (de)
ES (1) ES2226514B2 (de)
FI (1) FI20011703L (de)
GB (1) GB2364641B (de)
IL (1) IL144955A (de)
MX (1) MXPA01008550A (de)
NO (1) NO20014101L (de)
SE (1) SE0102843L (de)
WO (1) WO2000050046A1 (de)
ZA (1) ZA200106451B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7147873B2 (en) 2002-01-16 2006-12-12 3M Innovative Properties Company Antiseptic compositions and methods
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
US8440252B2 (en) * 2004-12-24 2013-05-14 Council Of Scientific And Industrial Research Iodized salt and a process for its preparation
JP4885877B2 (ja) 2005-01-10 2012-02-29 セクレタリー・デパートメント・オブ・アトミック・エナジー 被影響体のインビボ環境から放射性セシウム（＊Ｃｓ）、放射性ストロンチウム（＊Ｓｒ）、および放射性ヨウ素（＊Ｉ）を同時除染する予防混合物
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
ES2978927T3 (es) 2012-03-29 2024-09-23 Epion Therapeutics Inc Soluciones de tratamiento ocular, dispositivos de administración y métodos de aumento de la administración
US9555111B2 (en) 2012-03-29 2017-01-31 Cxl Ophthalmics, Llc Ocular cross-linking system and method for sealing corneal wounds
US9566301B2 (en) 2012-03-29 2017-02-14 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
WO2015080984A1 (en) 2013-11-27 2015-06-04 BioPharmX, Inc. Solid oral dosage form for breast symptoms
WO2015120458A1 (en) 2014-02-10 2015-08-13 Fred Hutchinson Cancer Research Center Halogen treatment of heart attack and ischemic injury
US20170304359A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
JP7516046B2 (ja) 2016-07-21 2024-07-16 アイ２ピュア・コーポレーション エモリエント性の局所消毒剤
US20190105344A1 (en) * 2016-09-16 2019-04-11 Jack Kessler Oral molecular iodine composition and method
AU2019282820A1 (en) * 2018-06-08 2021-01-21 Faraday Pharmaceuticals, Inc. Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndrome
EP4196094A4 (de) 2020-08-13 2024-11-13 I2Pure Corp. Zusammensetzungen mit hoher konzentration an molekularem iod, pharmazeutische formulierungen, herstellung und verwendungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486317A (en) * 1981-01-16 1984-12-04 E. I. Du Pont De Nemours And Company Stabilization of thickened aqueous fluids
RO85156B1 (ro) * 1983-05-27 1984-11-30 Institutul De Stiinte Biologice Comprimate-reactiv pentru determinarea alfa-anilazei si procedeu de obtinere a acestora
CN1036629C (zh) * 1991-03-16 1997-12-10 李克亮 动物促长剂
US5885592A (en) * 1997-10-29 1999-03-23 Symbollon Corporation Methods and pharmaceutical compositions for oral delivery of molecular iodine
EP1044689A4 (de) * 1998-01-06 2002-07-03 Fujisawa Pharmaceutical Co Feste jodophorzusammensetzungen und verfahren zur ihrer herstellung
US5985340A (en) * 1998-01-19 1999-11-16 Bolentica, Inc. Method for preparing iodine supplement for animal feeds

Also Published As

Publication number Publication date
CA2366679C (en) 2007-05-01
ES2226514A1 (es) 2005-03-16
GB2364641A (en) 2002-02-06
DK200101258A (da) 2001-10-26
SE0102843L (sv) 2001-10-26
CA2366679A1 (en) 2000-08-31
CN1344163A (zh) 2002-04-10
SE0102843D0 (sv) 2001-08-27
FI20011703A7 (fi) 2001-10-16
DE10084290T1 (de) 2003-04-03
ATA90122000A (de) 2005-10-15
JP2002537341A (ja) 2002-11-05
AU778774B2 (en) 2004-12-23
AT413795B (de) 2006-06-15
GB0122808D0 (en) 2001-11-14
NO20014101D0 (no) 2001-08-23
BR0008509A (pt) 2002-02-05
GB2364641B (en) 2004-06-30
ES2226514B2 (es) 2007-02-16
FI20011703A0 (fi) 2001-08-24
AU3371300A (en) 2000-09-14
KR20010103014A (ko) 2001-11-17
DK176595B1 (da) 2008-10-20
ZA200106451B (en) 2002-08-06
IL144955A (en) 2006-12-31
US6248335B1 (en) 2001-06-19
FI20011703L (fi) 2001-10-16
IL144955A0 (en) 2002-06-30
WO2000050046A8 (en) 2003-11-27
MXPA01008550A (es) 2003-08-19
KR100674324B1 (ko) 2007-01-24
WO2000050046A1 (en) 2000-08-31

Similar Documents

Publication Publication Date Title
NO20014101L (no) Stabilisert oral farmasöytisk blanding inneholdende iodid og iodat og fremgangsmåte
DK1200418T3 (da) Nematodicide trifluorbutener
CY1107506T1 (el) Μεθοδος για σταθεροποιηση ενωσεων βενζιμιδαζολης
DE60112609D1 (en) Pyrazolopyridine
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
DK0915898T3 (da) Krystalform I af clarithromycin
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
DK0548114T5 (da) Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette
AU2002239348A1 (en) Pyrazolopyridine derivatives
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
DK0579681T3 (da) Krystallinsk tiagabin-hydrochlorid-monohydrat, dets fremstilling og dets anvendelse
NO20050664L (no) 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
IL157540A (en) Pharmaceutical compositions comprising n-(aryl)-2-arylethenesulfonamides, some such novel compounds and process for their preparation
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
AU2002248531A1 (en) Pyrazolopyriadine derivatives
NO20044466L (no) Plasma-karboksypeptidase B-inhibitorer
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine
SE0002354D0 (sv) New formulation
ES2062940A1 (es) Agente gastrocinetico, proceso para su preparacion y composiciones farmaceuticas que lo contengan.
NO20014889L (no) Fremgangsmåte for fremstilling av medisinske midler
NO303640B1 (no) Ny forbindelse, Leustroducsin H, farmas°ytisk preparat som omfatter den, og dens anvendelse til fremstilling av et slikt preparat
SE9803277D0 (sv) Novel compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application